“Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection” (2020) Biomolecules and Biomedicine, 20(3), pp. 401–410. doi:10.17305/bjbms.2019.4576.